Search All News
A public battle rages over access to experimental, trial-phase drugs
Neil Shneider, Stockman-Mauriello’s doctor and director of the Eleanor and Lou Gehrig ALS Center at Columbia University in New York, nonetheless asked Biogen for access.
Source:The Wall Street Journal
“Anything that can slow down the rate of decline in a disease that has no cure—or no treatment to reverse symptoms—is good,” said Jinsy Andrews.
Source:The New York TimesSeptember 2, 2020
“This is very encouraging,” said Dr. Neil Shneider, director of the Eleanor and Lou Gehrig A.L.S. Center at Columbia University, who was not involved.
Jinsy Andrews, MD, MSc, FAAN has been elected co-chair of the Northeast ALS Consortium (NEALS) for a four-year term.